Skip to content

Erector Spinae Plane Block for Acute Back Pain in the Emergency Department

Erector Spinae Plane Block for Acute Back Pain in the Emergency Department

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06745453
Enrollment
62
Registered
2024-12-20
Start date
2025-02-03
Completion date
2026-12-31
Last updated
2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

erector spinae plane block, emergency department, low back pain, regional anesthesia, nerve block

Brief summary

The goal of this clinical trial is to learn if an erector spinae plane block (ESPB; a type of nerve block) works to reduce pain in adults presenting to the emergency department with low back pain. It will also learn if the ESPB reduces pain, disability, and return to work at 7 days. The main questions it aims to answer are: 1. Does the ESPB reduce short-term pain in participants with low back pain? 2. Does the ESPB reduce longer-term pain, reduce disability, and improve return to work and activities in participants with low back pain? Researchers will compare ESPB to a placebo (an injection that does not involve a nerve block) to see if ESPB works to treat low back pain. Participants will: Receive either the ESPB or a placebo injection in the emergency department Report their pain scores for up to 120 minutes Report their pain, disability, and return to work at 7 days

Interventions

PROCEDUREErector Spinae Plane Block

Erector Spinae Plane Block

PROCEDURESham Procedure

Sham Procedure

Sponsors

Rush University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (age ≥18 years) presenting to the emergency department with isolated low back pain present less than 6 total weeks.

Exclusion criteria

* Do not speak English or Spanish as a primary language * Are incarcerated * Have a known pregnancy * Are allergic to amide-type local anesthetics * Are unable to tolerate positioning for the procedure * Have a critical illness precluding the ability to perform the procedure.

Design outcomes

Primary

MeasureTime frameDescription
Pain score at 120 minutes post-intervention as assessed using a 10-point numeric rating scaleChange from baseline to 120 minutes post-interventionZero is equivalent to no pain and 10 indicates worst pain imaginable

Secondary

MeasureTime frameDescription
Pain score at 30 minutes post-intervention as assessed using a 10-point numeric rating scaleChange from baseline to 30 minutes post-interventionZero is equivalent to no pain and 10 indicates worst pain imaginable
Pain score at 60 minutes post-intervention as assessed using a 10-point numeric rating scaleChange from baseline to 60 minutes post-interventionZero is equivalent to no pain and 10 indicates worst pain imaginable
Degree of disability assessed via the Roland-Morris disability questionnaire at 7 daysAssessed as the change in Roland-Morris disability questionnaire scores between baseline and 7 day follow upParticipants will be scored using the validated Roland-Morris disability questionnaire.
Pain score at 7 days post-intervention as assessed using a 10-point numeric rating scalePain score assessed at 7 days post-interventionZero is equivalent to no pain and 10 indicates worst pain imaginable
Opioid medications taken in the 7 days following the interventionMeasured at 7 days post-interventionCalculated in morphine milligram equivalents
Follow up visits related to low back pain in the 7 days following the interventionAssessed at 7 daysBased upon patient self-report
Return to work and activities assessed via the Work Productivity and Activity Impairment Questionnaire: General Health version 2.0Assessed at 7 daysAssessed using the validated Work Productivity and Activity Impairment Questionnaire: General Health version 2.0 questionnaire

Countries

United States

Contacts

CONTACTAylin Ornelas Loredo, MMS
aylin_a_ornelasloredo@rush.edu312-563-0645
CONTACTMichelle Santangelo, MS
michelle_santangelo@rush.edu312-563-0645
PRINCIPAL_INVESTIGATORMichael Gottlieb, MD

Rush University Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026